drug development

Biogen To Pay Ionis $1 Billion To Develop Brain Drugs
Biogen To Pay Ionis $1 Billion To Develop Brain Drugs
Forbes
Biogen
Ionis Pharmaceuticals
drug development
R&D
Flag link:
FDA chief Scott Gottlieb promises to streamline drug development pathway for biopharma
FDA chief Scott Gottlieb promises to streamline drug development pathway for biopharma
Endpoints
FDA
Scott Gottlieb
drug development
Flag link:
Nosopharm and University of Chicago Researchers Report on New Class of Antibiotics
Nosopharm and University of Chicago Researchers Report on New Class of Antibiotics
CP Wire
Nosopharm
antibiotics
drug development
Flag link:
FDA Wants to Know What Prevents Exposure-Response Analyses in Drug Development
FDA Wants to Know What Prevents Exposure-Response Analyses in Drug Development
RAPS.org
FDA
exposure-response analyses
drug development
Flag link:
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Drug Delivery Business News
Eli Lilly
Sigilon
cell therapies
drug development
type 1 diabetes
Flag link:
Pfizer signs deal with Allogene to develop cancer cell therapy
Pfizer signs deal with Allogene to develop cancer cell therapy
Yahoo/Reuters
Pfizer
Allogene
CAR-T
drug development
Flag link:
Compugen, AstraZeneca unit in cancer drug development deal
Compugen, AstraZeneca unit in cancer drug development deal
Yahoo/Reuters
AstraZeneca
CompuGen
drug development
MedImmune
cancer
Flag link:
Celgene, bluebird revise deal to co-develop CAR-T therapy
Celgene, bluebird revise deal to co-develop CAR-T therapy
Biopharma Dive
Celgene
Bluebird Bio
drug development
CAR-T
bb2121
Multiple Myeloma
Flag link:
CDI Labs' Monoclonal Antibody Development Pipeline Featured in Nature Methods
CDI Labs' Monoclonal Antibody Development Pipeline Featured in Nature Methods
CP Wire
CDI Labs
monoclonal antibodies
drug development
Flag link:
Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei
Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei
Endpoints
Teva Pharmaceutical
CGRP blockers
R&D
drug development
Heptares Therapeutics
Flag link:
Vividion Lands $101M from Celgene to Develop Protein-Targeting Drugs
Vividion Lands $101M from Celgene to Develop Protein-Targeting Drugs
Xconomy
Vividion
Celgene
drug development
protein-targeted drugs
Flag link:
Despite push for a universal flu vaccine, the ‘holy grail’ stays out of reach
Despite push for a universal flu vaccine, the ‘holy grail’ stays out of reach
Stat
drug development
Flu
flu vaccines
universal flu vaccine
Flag link:
Pfizer, Roche and Allergan Weigh FDA Plans for Patient-Focused Drug Development Guidance
Pfizer, Roche and Allergan Weigh FDA Plans for Patient-Focused Drug Development Guidance
RAPS.org
Pfizer
Roche
Allergan
FDA
patients
drug development
Flag link:
Pharma Must Use Tax-Reform Windfall To Make More Drugs Or Face Backlash - Part II
Pharma Must Use Tax-Reform Windfall To Make More Drugs Or Face Backlash - Part II
Forbes
tax reform
drug development
Flag link:
Takeda surfs a potential $2B Wave of acquisitions
Takeda surfs a potential $2B Wave of acquisitions
Biopharma Dive
Takeda
M&A
Wave Life Sciences Ltd
drug development
CNS
Flag link:
How Pharma Can Minimize Political Risk From Its Repatriation Windfall
How Pharma Can Minimize Political Risk From Its Repatriation Windfall
Forbes
pharma industry
reputation
repatriation
taxes
drug development
Flag link:
With weeks left in flu season, the FDA is already working on next year’s vaccine
With weeks left in flu season, the FDA is already working on next year’s vaccine
Drug Delivery Business News
FDA
Flu
influenza
vaccines
flu vaccines
drug development
Flag link:
FDA looks to pave way for earlier-stage Alzheimer's drugs
FDA looks to pave way for earlier-stage Alzheimer's drugs
Yahoo/Reuters
FDA
Alzheimer's disease
drug development
Flag link:
$100B in NIH-funded research played an important role in all 210 new drugs approved over 7 years — study
$100B in NIH-funded research played an important role in all 210 new drugs approved over 7 years — study
Endpoints
R&D
drug development
NIH
research funding
Flag link:
What’s the trouble with pain? Analysis shows scarce investments, high failure rate for new drugs
What’s the trouble with pain? Analysis shows scarce investments, high failure rate for new drugs
Endpoints
painkillers
drug development
R&D
Flag link:

Pages